Beranda › Penyakit Ginjal Kronis › Tennessee
Uji klinis Penyakit Ginjal Kronis di Tennessee
14 studi untuk Penyakit Ginjal Kronis mencari peserta di lokasi di Tennessee.
Kota di Tennessee
Teks studi resmi (Bahasa Inggris)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #4, Chattanooga
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07268638A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
- Research Site, Chattanooga
- Research Site, Knoxville
- Research Site, Knoxville
- dan 1 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06742723A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)
- Research Site, Chattanooga
Menerima pesertaFase 3
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 24 Sep 2026 · NCT07624305Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN
- University of Tennessee Health Science Center- Le Bonheur Research Center, Memphis
Menerima pesertaFase 3
Usia 2 hingga 18 · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT07498335A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
- Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 3
Usia 2 hingga 17 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT07107945Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Southeast Renal Research Institute, Chattanooga
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT07271186A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
- Research Site, Morristown
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07753993Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
- Memphis VA Medical Center, Memphis, TN, Memphis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT05465044Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
- Knoxville Kidney Center Pllc, Brentwood
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06858319Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
- Vanderbilt University Medical Center, Nashville
Menerima pesertaFase 2
Usia 21 hingga 85 · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT04984226Empagliflozin Treatment in Kidney Transplant Recipients
- Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
Menerima pesertaFase 4
Usia 19 ke atas · Semua jenis kelamin · Diperbarui 21 Apr 2026 · NCT06013865Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage
- Vanderbilt University Medical Center, Nashville
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT07385651SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
- James Eric Gardner, MD, PC, Memphis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT06001827Pharmacy-led Transitions of Care Intervention to Improve Medication Adherence
- University of Tennessee Medical Center, Knoxville
- University of Tennessee Health Science Center/Regional One Health, Memphis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jan 2026 · NCT06374277Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.